Table 3.

The Numbers (Ratios) of Impaired/Decreased Platelet Aggregation on Different TKI Treatments.

	İmatinib, n = 47	Dasatinib, n = 15	Nilotinib, n = 6	P
ADP (2 µM)	12 (25.5%)	5 (33.3%)	1 (16.6%)	.71
ADP (6 µM)	3 (6.4%)	4 (26.6%)	1 (16.6%)	.09
Epinephrine	8 (17%)	5 (33.3%)	2 (33.3%)	.01
Collagen	2 (4.2%)	2 (13.3%)	0	.002
Ristocetin (1.25 mg/mL)	2 (4.2%)	0	0	.63
Ristocetin (0.6 mg/mL)	47 (100%)	14 (93.3%)	6 (100%)	.55

Abbreviations: ADP, adenosine diphosphate; TKIs, tyrosine kinase inhibitors.